CN101934029B - Chinese medicament for treating liver cirrhosis ascites - Google Patents
Chinese medicament for treating liver cirrhosis ascites Download PDFInfo
- Publication number
- CN101934029B CN101934029B CN2009100661107A CN200910066110A CN101934029B CN 101934029 B CN101934029 B CN 101934029B CN 2009100661107 A CN2009100661107 A CN 2009100661107A CN 200910066110 A CN200910066110 A CN 200910066110A CN 101934029 B CN101934029 B CN 101934029B
- Authority
- CN
- China
- Prior art keywords
- ascites
- ganoderma
- radix bupleuri
- rhizoma polygonati
- herba patriniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010003445 Ascites Diseases 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract description 6
- 241000222336 Ganoderma Species 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 13
- 238000005303 weighing Methods 0.000 description 12
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 238000003801 milling Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicament for treating liver cirrhosis ascites. The Chinese medicament is prepared from the following raw materials in part by weight: 2 to 15 parts of white-flower patrinia herb, 2 to 15 parts of bupleurum, 2 to 10 parts of Siberian solomonseal rhizome, 2 to 15 parts of Chinese quince and 2 to 15 parts of glossy ganoderma. The Chinese medicament is a pure Chinese medicament preparation, has no toxic or side effect, and can treat various tumor ascites, liver cirrhosis ascites and pleural ascites, resist tumors, protect liver and resist viruses.
Description
Technical field
The invention belongs to Chinese medicine, be specifically related to a kind of Chinese medicine of treating cirrhotic ascites.
Background technology
Liver cirrhosis is the principal disease that causes ascites, and in a single day ascites appear in liver cirrhosis patient, indicates that sclerosis has got into the mistake compensatory phase (middle and advanced stage).The early stage of ascites occur, the patient only has slight abdominal distention, is easy to think by mistake to be that digestion is bad, if therefore chronic hepatitis especially liver cirrhosis patient is felt that in the recent period abdominal distention is obvious, waistline increase, body weight gain, edema of lower limbs should in time arrive examination in hospital.The main cause that ascites forms is: portal venous pressure rising, albumin reduction, the minimizing of kidney effective circulating blood volume, endocrine dysfunction etc.Doctor trained in Western medicine generally gives excision, chemotherapy, radiotherapy or interventional therapy according to the state of an illness for the therapeutic scheme of ascites.This not only brings misery to the patient, and medical fee is expensive.The traditional Chinese medical science thinks that traditional medicine thinks that cirrhotic ascites is to receive disease by liver, lung, kidney; Cause the water-electrolyte metabolism obstacle in gas, blood, the water alluvial body; Cause stagnation of QI due to depression of the liver blood stasis, the hepatic and renal YIN deficiency, deficiency of spleen-YANG and kidneyYANG, retention of water-damp in the body, treat with blood stasis dispelling, invigorate the spleen and warm the kidney, blood stasis dispelling row water through regulating the flow of QI to dissipate blood stasis, heat clearing away purging FU-organs, blood circulation promoting and blood stasis dispelling, replenishing QI to invigorate the spleen, inducing diuresis to remove edema, yin nourishing diuretic, assistant.
Summary of the invention
The technical problem that the present invention will solve is that the western medical treatment scheme of cirrhotic ascites is brought misery to the patient, and medical fee is expensive, and a kind of Chinese medicine of treating cirrhotic ascites is provided.
The technical scheme that the present invention adopts is following:
Medicine of the present invention is to be processed by the raw material of following parts by weight: Herba Patriniae 2～15, Radix Bupleuri 2～15, Rhizoma Polygonati 2～10, Fructus Chaenomelis 2～15, Ganoderma 2～15.
The preferred weight umber of preparation medicine material of the present invention is: Herba Patriniae 6～8, Radix Bupleuri 6～8, Rhizoma Polygonati 6～8, Fructus Chaenomelis 6～8, Ganoderma 6～8.
The optimum weight umber of preparation medicine material of the present invention is: Herba Patriniae 8, Radix Bupleuri 6, Rhizoma Polygonati 6, Fructus Chaenomelis 6, Ganoderma 6.
Among the present invention, Herba Patriniae: cool in nature, acrid in the mouth, hardship, heat-clearing and toxic substances removing, removing blood stasis and expelling pus is used for appendicitis, dysentery, enteritis, hepatitis, eye conjunctivitis, postnatal blood stasis stomachache, carbuncle furuncle; Radix Bupleuri: hardship, be slightly cold, return liver, gallbladder meridian, reconciling superficies and interior, soothing the liver, yang invigorating is used for cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium, menoxenia, uterine prolapse, proctoptosis, AFL, anti-liver injury, function of gallbladder promoting, transaminase lowering, antibiotic, antiviral; Rhizoma Polygonati: sweet, flat, return lung, spleen; Kidney channel, nourishing kidney profit spleen, invigorating the spleen and replenishing QI, boosting qi and nourishing yin; Spleen invigorating, lung moistening, kidney tonifying; Have resisting pathogenic microbes, suppress that blood glucose is too high, resisting fatigue, antioxidation, hemostasis, immunomodulating, antiinflammatory, antivirus action also can be used for leukopenia, pulmonary tuberculosis, chronic hepatitis, chemical liver injury are had protective effect; Fructus Chaenomelis: acid, temperature is returned liver, spleen channel, the suppressing the hyperactive liver Shujin, the stomach function regulating removing dampness is used for the arthralgia chiefly caused by damp pathogen contracture, the heavy pain of waist knee joint acid, the convulsion of vomiting and diarrhoea, the beriberi edema alleviates hepatocellular degeneration, necrosis, promotes hepatocyte to repair, and suppresses ascites and growth of cancer cells; Ganoderma: sweet, flat.GUIXIN, lung, liver, kidney channel.Cure mainly asthenia, cough, asthma, insomnia, dyspepsia, have immunomodulating, antioxidation is anti-ageing, hypoglycemic, treatment all kinds hepatitis, malignant tumor etc.
Method for preparing of the present invention: with Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 1～2 hour at a simmer or with Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 30～40 minutes at a simmer.
Usage and dosage: 1 dose of every day, day clothes 2 times, one after each meal, every agent medicine contain Herba Patriniae 2～15g, Radix Bupleuri 2～15g, Rhizoma Polygonati 2～10g, Fructus Chaenomelis 2～15g, Ganoderma 2～15g.
The invention has the beneficial effects as follows: this medicine is a pure Chinese medicinal preparation, has no side effect, and can treat various tumor ascites, cirrhotic ascites, pleura ascites, antitumor, protect the liver antiviral.
The specific embodiment
Embodiment 1
Take by weighing raw material by following weight proportion:
Herba Patriniae 2g, Radix Bupleuri 2g, Rhizoma Polygonati 10g, Fructus Chaenomelis 15g, Ganoderma 2g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 1 hour at a simmer.
Embodiment 2
Take by weighing raw material by following weight proportion:
Herba Patriniae 15g, Radix Bupleuri 2g, Rhizoma Polygonati 10g, Fructus Chaenomelis 2g, Ganoderma 15g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 2 hours at a simmer.
Embodiment 3
Take by weighing raw material by following weight proportion:
Herba Patriniae 3g, Radix Bupleuri 6g, Rhizoma Polygonati 8g, Fructus Chaenomelis 9g, Ganoderma 10g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 1.5 hours at a simmer
Embodiment 4
Take by weighing raw material by following weight proportion:
Herba Patriniae 10g, Radix Bupleuri 8g, Rhizoma Polygonati 8g, Fructus Chaenomelis 8g, Ganoderma 10g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 2 hours at a simmer
Embodiment 5
Take by weighing raw material by following weight proportion:
Herba Patriniae 6g, Radix Bupleuri 4g, Rhizoma Polygonati 8g, Fructus Chaenomelis 12g, Ganoderma 12g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma with 1 hour at a simmer
Embodiment 6
Take by weighing raw material by following weight proportion:
Herba Patriniae 2g, Radix Bupleuri 15g, Rhizoma Polygonati 8g, Fructus Chaenomelis 14g, Ganoderma 3g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 30 minutes at a simmer.
Embodiment 7
Take by weighing raw material by following weight proportion:
Herba Patriniae 4g, Radix Bupleuri 6g, Rhizoma Polygonati 9g, Fructus Chaenomelis 10g, Ganoderma 12g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 40 minutes at a simmer.
Embodiment 8
Take by weighing raw material by following weight proportion:
Herba Patriniae 11g, Radix Bupleuri 13g, Rhizoma Polygonati 7g, Fructus Chaenomelis 8g, Ganoderma 6g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 40 minutes at a simmer.
Embodiment 9
Take by weighing raw material by following weight proportion:
Herba Patriniae 15g, Radix Bupleuri 9g, Rhizoma Polygonati 6g, Fructus Chaenomelis 3g, Ganoderma 8g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 35 minutes at a simmer.
Embodiment 10
Take by weighing raw material by following weight proportion:
Herba Patriniae 12g, Radix Bupleuri 5g, Rhizoma Polygonati 9g, Fructus Chaenomelis 15g, Ganoderma 15g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 30 minutes at a simmer.
Embodiment 11
Take by weighing raw material by following weight proportion:
Herba Patriniae Herba Patriniae 8g, Radix Bupleuri 6g, Rhizoma Polygonati 6g, Fructus Chaenomelis 6g, Ganoderma 6g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 40 minutes at a simmer.
Embodiment 12
Take by weighing raw material by following weight proportion:
Herba Patriniae Herba Patriniae 8g, Radix Bupleuri 9g, Rhizoma Polygonati 6g, Fructus Chaenomelis 10g, Ganoderma 6g.
Method for preparing:
With Herba Patriniae, Radix Bupleuri, Rhizoma Polygonati, Fructus Chaenomelis, Ganoderma through milling process processing, again with medicine powder with 35 minutes at a simmer.
Model case
Feng, the Lin Qi town pays people from village, man, 54 years old.Be diagnosed as hepatocarcinoma, cirrhotic ascites, tripe was big like drum at that time, the extremity edema, through taking this medicine 10 days, the ascites edema disappears, and tumor and sclerosis disappearance after three months are still alive now.
Guo, Xi Yu people from village, Cha Dian township, the man, 74 years old, suffer from hepatic ascites, 7 days ascites disappears behind the Chinese herbal medicine of taking my preparation, never has ascites subsequently.
Zhang, Lin Qi faces in the town river in Henan Province people, the man, 53 years old, suffer from cirrhotic ascites to the Anyang Fifth Academy of Aerospace Industry treatment repeatedly, ascites can not be controlled always, after take this medicine left and right sides on the 10th ascites and disappear, still taking at present.
Claims (3)
1. a Chinese medicine of treating cirrhotic ascites is characterized in that it is to be processed by the raw material of following parts by weight: Herba Patriniae 2～15, Radix Bupleuri 2～15, Rhizoma Polygonati 2～10, Fructus Chaenomelis 2～15, Ganoderma 2～15.
2. the Chinese medicine of treatment cirrhotic ascites according to claim 1 is characterized in that it is to be processed by the raw material of following parts by weight: Herba Patriniae 6～8, Radix Bupleuri 6～8, Rhizoma Polygonati 6～8, Fructus Chaenomelis 6～8, Ganoderma 6～8.
3. the Chinese medicine of treatment cirrhotic ascites according to claim 1 is characterized in that it is to be processed by the raw material of following parts by weight: Herba Patriniae 8, Radix Bupleuri 6, Rhizoma Polygonati 6, Fructus Chaenomelis 6, Ganoderma 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100661107A CN101934029B (en) | 2009-09-10 | 2009-09-10 | Chinese medicament for treating liver cirrhosis ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100661107A CN101934029B (en) | 2009-09-10 | 2009-09-10 | Chinese medicament for treating liver cirrhosis ascites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101934029A CN101934029A (en) | 2011-01-05 |
| CN101934029B true CN101934029B (en) | 2012-02-29 |
Family
ID=43387750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100661107A Expired - Fee Related CN101934029B (en) | 2009-09-10 | 2009-09-10 | Chinese medicament for treating liver cirrhosis ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101934029B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524262A (en) * | 2014-12-10 | 2015-04-22 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | Traditional Chinese medicine for treating ascites due to cirrhosis |
| CN104840554A (en) * | 2015-05-27 | 2015-08-19 | 傅宇晓 | Capsules for treating ascites due to cirrhosis and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
-
2009
- 2009-09-10 CN CN2009100661107A patent/CN101934029B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
Non-Patent Citations (2)
| Title |
|---|
| 易桂生.中医药治疗肝硬化腹水近况.《中医药信息》.1998,(第4期),第11-13页. * |
| 李文艳.近5年肝硬化腹水的中医治疗概况.《甘肃中医》.1996,第9卷(第5期),第46-48页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101934029A (en) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100528211C (en) | Traditional Chinese medicine for treating tumor | |
| CN104491740B (en) | A kind of Chinese medicine composition for treating liver cancer and preparation method thereof | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN101284101A (en) | Chinese traditional medicine for curing fatty liver and hyperlipemia | |
| CN102114099B (en) | Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof | |
| CN101934029B (en) | Chinese medicament for treating liver cirrhosis ascites | |
| CN104324331A (en) | Lung tumor suppression cream applied to Qi-stagnation and blood stasis and preparation method of lung tumor suppression cream | |
| CN103405682A (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN111671864A (en) | Traditional Chinese medicine preparation for relieving bone marrow suppression caused by chemotherapy and preparation method thereof | |
| CN103638234B (en) | A kind of Chinese medicine composition, preparation and preparation method thereof for the treatment of tinnitus | |
| CN101797369A (en) | Traditional Chinese medicinal composition for treating gastric atony | |
| CN102114227B (en) | Pharmaceutical composition for treating hepatitis B and cirrhosis | |
| CN108904700A (en) | A kind of drug and preparation method thereof for preventing and treating blue otopathy | |
| CN103432539B (en) | Chinese herbal preparation for dispelling damp-heat and damp-toxin | |
| CN101816745A (en) | Traditional Chinese medicine composition suitable for treating ascites due to cirrhosis and preparation method thereof | |
| CN103169838B (en) | Medicine for treating hepatitis B | |
| CN102488804B (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN104587056B (en) | A kind of Chinese medicine preparation and preparation method thereof for treating varicocele | |
| CN104352984A (en) | Lung tumor-inhibiting paste suitable for excessive toxic heat and preparation method thereof | |
| CN1985902B (en) | Chinese medicine for treating chronic hepatopathy | |
| CN103977276A (en) | Traditional Chinese medicine capsule used for treating radiocystitis | |
| CN102961704A (en) | Pharmaceutical composition for treating liver caner and method for preparing dispersible tablets thereof | |
| CN105749181A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method of traditional Chinese medicine composition | |
| CN107468949B (en) | Traditional Chinese medicine composition for treating advanced primary liver cancer and preparation method thereof | |
| Wang | Research on Internal Treatment of Cough Variant Asthma with Traditional Chinese Medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120229 Termination date: 20120910 |